Y-1731 Glucose Saline Solution Manufacturing Plant (IV fluids Used in Hospitals, Nursing Homes). Investment Opportunities in Pharma Sector www.entrepreneurindia.co www.niir.org Introduction Dextrose solution, also known as intravenous sugar solution, is a combination of dextrose (glucose) and water administered intravenously. It's used to treat low blood sugar and water loss but doesn't result in electrolyte loss. Fever, hyperthyroidism, high blood calcium, and diabetes insipidus can all cause water loss without electrolyte loss. It is required when an individual is ill, going through an operation or is not in the condition to eat or drink. www.entrepreneurindia.co www.niir.org IV solutions and electrolytes are mainly used for fluid resuscitation, routine maintenance, replaGlucose Saline , and redistribution. It is needed when a person is sick, undergoing surgery, or unable to eat or drink. Fluid resuscitation, routine cleaning, replaGlucose Saline , and redistribution are all common uses for IV solutions and electrolytes. Irritation of the vein into which it is injected, elevated blood sugar, and swelling are all possible side effects. www.entrepreneurindia.co www.niir.org Excessive use can lead to low blood sodium levels and other electrolyte issues. The crystalloid family of drugs includes intravenous sugar solutions. They are available in a variety of strengths, including 5%, 10%, and 50% dextrose. While they may start out hypertonic, as the sugar is metabolized, they become hypotonic. There are also versions that are combined with saline. Crystalloid and, less often, colloidal solutions are administered intravenously in intravenous fluid therapy. www.entrepreneurindia.co www.niir.org The type, volume, and rate of infusion of fluids are dictated by the indication for fluid therapy and the particular needs of the patient. Crystalloid solutions are used to resuscitate hypovolemic or dehydrated patients, correct free water deficits, replace chronic fluid losses, and satisfy the fluid needs of patients who are unable to drink fluids. Colloidal solutions are controversial and can only be used under exceptional circumstances (e.g., severe cases of low oncotic pressure). www.entrepreneurindia.co www.niir.org Fluid therapy should be properly de-escalated for patients in rehabilitation to prevent fluid exhaustion, and all patients should be closely monitored using a combination of clinical criteria and laboratory testing to assess therapeutic endpoints. www.entrepreneurindia.co www.niir.org Uses of Glucose Saline Intravenous solution is used to treat low blood sugar and water loss but does not result in electrolyte loss. Fever, hyperthyroidism, high blood calcium, and diabetes insipidus can all cause water loss without electrolyte loss. It's also used to treat elevated potassium levels in the blood, diabetic ketoacidosis, and as part of parenteral nutrition. www.entrepreneurindia.co www.niir.org Pre- and postoperative administration of a 5% sugar solution normally maintains a reasonable balance between starvation reactions and hyperglycemia caused by sympathetic activation. After one day after surgery, when the stress response from the reaction has subsided, a 10% solution might be more suitable. After approximately two days, a more comprehensive total parenteral diet regimen is recommended. www.entrepreneurindia.co www.niir.org Intravenous fluids are used to provide fluids to the body when it needs more fluids and electrolytes. 1. It’s used to administer other medications as a shot. 2. It may be offered to you for a variety of purposes. Consult the physician. www.entrepreneurindia.co www.niir.org Market Outlook In clinical medicine, intravenous solutions are often used to replace and maintain body fluids. They are given to people who have lost body fluids due to dehydration or other medical conditions. Intravenous solutions are injected directly into the veins to offer immediate relief to those receiving care. Diarrhea is the world's second leading cause of death, affecting nearly 1.7 billion people, according to the World Health Organization (WHO). Every year, it kills 525,000 people. www.entrepreneurindia.co www.niir.org 9 percent regular saline, lactated ringers, 5 percent dextrose in water, and others make up the global intravenous solution market. The global intravenous solution market can be divided into three types of distribution channels: hospital pharmacies, drug stores, and specialty pharmacies. Regulatory and consistency criteria, on the other hand, add to the market's cost and uncertainty. www.entrepreneurindia.co www.niir.org Despite being marketed at reasonably low rates, intravenous fluids are regulated as medicinal products and must meet many of the capital expenditure standards of sterile injectable drugs, limiting market development. www.entrepreneurindia.co www.niir.org Key Players Amanta Healthcare Ltd. Baxter Pharmaceuticals India Pvt. Ltd. Bayer Pharmaceuticals Pvt. Ltd. Denis Chem Lab Ltd. Meridian Enterprises Pvt. Ltd. Pfizer Healthcare India Pvt. Ltd. www.entrepreneurindia.co www.niir.org Pfizer Ltd. Pharmacia Healthcare Ltd. Shree Krishna Keshav Laboratories Ltd. Vikrant Pharmaceuticals Ltd. Wockhardt Health Care Ltd. www.entrepreneurindia.co www.niir.org Machinery Photographs Vacuum Distillation Plant www.entrepreneurindia.co www.niir.org CA-20 Water Chiller Oil-free Air Compressor www.entrepreneurindia.co www.niir.org Leakage Checking Semi-Automatic Lamp Machine Inspection Machine www.entrepreneurindia.co www.niir.org Project at a Glance www.niir.org COST OF PROJECT MEANS OF FINANCE Propose Particulars Existing Proposed Total Particulars Existing d Total Land & Site Development Exp. 0.00 350.00 350.00Capital 0.00 1020.82 1020.82 Buildings 0.00 905.00 905.00Share Premium 0.00 0.00 0.00 Other Type Share Plant & Machineries 0.00 2170.00 2170.00Capital 0.00 0.00 0.00 Motor Vehicles 0.00 20.00 20.00Reserves & Surplus 0.00 0.00 0.00 Office Automation Equipments 0.00 82.50 82.50Cash Subsidy 0.00 0.00 0.00 Technical Knowhow Fees & Exp. 0.00 150.00 150.00Internal Cash Accruals 0.00 0.00 0.00 Franchise & Other Long/Medium Term Deposits 0.00 0.00 0.00Borrowings 0.00 3062.46 3062.46 Preliminary& Pre- operative Exp 0.00 5.00 5.00Debentures / Bonds 0.00 0.00 0.00 Provision for Unsecured Contingencies 0.00 191.00 191.00Loans/Deposits 0.00 0.00 0.00 Margin Money - Working Capital 0.00 209.78 209.78 TOTAL 0.00 4083.28 4083.28TOTAL 0.00 4083.28 4083.28 www.entrepreneurindia.co Project at a Glance www.niir.org Year Annualised Book Debt Dividend Retained Payout Probable P/E Yield Price/ Value Earnings Market Ratio Book Value Price No.of Times Per EPS CEPS Per Share Share Per Share ` ` ` ` ` % ` % ` % 1-2 5.44 10.01 15.44 24.00 0.00 100.00 5.44 0.00 5.44 1.00 0.00 2-3 7.68 11.63 23.11 18.00 0.00 100.00 7.68 0.00 7.68 1.00 0.00 3-4 9.94 13.37 33.06 12.00 0.00 100.00 9.94 0.00 9.94 1.00 0.00 4-5 12.20 15.18 45.26 6.00 0.00 100.00 12.20 0.00 12.20 1.00 0.00 5-6 14.44 17.03 59.69 0.00 0.00 100.00 14.44 0.00 14.44 1.00 0.00 www.entrepreneurindia.co Project at a Glance www.niir.org Year D. S. C. R. Debt / - Equity Total Retur Profitability Ratio Assets Curre Deposit as- Net n on Turnov nt s Debt Equity Worth Net er Ratio Worth Ratio Indivi CumulatOver GPM PBT PAT Net P/V dual ive all Contri Ratio bution (Number of (Number of times) times) % % % % % % Initial 3.00 3.00 26.09 12.33 2589.7 57.55 1-2 1.46 1.46 1.55 1.55 1.96 % 16.52% % 7 % 0.99 1.01 29.46 14.93 2659.0 50.65 2-3 1.69 1.57 0.78 0.78 1.09 % 22.07% % 0 % 1.09 1.43 31.78 16.91 3030.2 50.50 3-4 1.97 1.69 1.98 0.36 0.36 0.61 % 26.02% % 3 % 1.12 1.92 33.39 18.45 3401.4 50.39 4-5 2.32 1.83 0.13 0.13 0.34 % 28.91% % 6 % 1.11 2.46 34.54 19.65 3772.6 50.30 5-6 2.73 1.98 0.00 0.00 0.17 % 31.05% % 8 % 1.06 4.83 www.entrepreneurindia.co Project at a Glance www.niir.org BEP BEP - Maximum Utilisation Year 5 Cash BEP (% of Installed Capacity) 29.66% Total BEP (% of Installed Capacity) 36.67% IRR, PAYBACK and FACR Internal Rate of Return .. ( In %age ) 24.67% Payback Period of the Project is ( In Years ) 2 Years 3 Months Fixed Assets Coverage Ratio ( No. of times ) 3.514 www.entrepreneurindia.co Major Queries/Questions Answered in the Report? 1. What is Glucose Saline Manufacturing industry ? 2. How has the Glucose Saline Manufacturing industry performed so far and how will it perform in the coming years ? 3. What is the Project Feasibility of Glucose Saline Manufacturing Plant ? 4. What are the requirements of Working Capital for setting up Glucose Saline Manufacturing plant ? www.niir.org www.entrepreneurindia.co 5. What is the structure of the Glucose Saline Manufacturing Business and who are the key/major players ? 6. What is the total project cost for setting up Glucose Saline Manufacturing Business? 7. What are the operating costs for setting up Glucose Saline Manufacturing plant ? 8. What are the machinery and equipment requirements for setting up Glucose Saline Manufacturing plant ? www.niir.org www.entrepreneurindia.co 9. Who are the Suppliers and Manufacturers of Plant & Machinery for setting up Glucose Saline Manufacturing plant ? 10.